Professional Documents
Culture Documents
Presented By:-
AAKASH WALIA
21340
2021-2023 Batch
Marketing Management
COMPANY PROFILE
VISSION & MISSION.
VALUES.
MARKET SHARE
•Company has delivered good profit growth of 34.89% CAGR over last 5 years
PRODUCT PORTFOLIOS:
Granules is among the largest manufacturers of first line of defence products (paracetamol, metformin, ibuprofen,
guaifenesin & methocarbamol).
ACTIVE PHARMACEUTICAL INGREDIENTS
FINISHED DOSAGES
Granules India gets USFDA nod for its generic Amphetamine mixed salts
The approval granted by the US Food and Drug Administration (USFDA) to Granules Pharmaceuticals, Inc (GPI), a
wholly-owned arm, is for the abbreviated new drug application (ANDA) of amphetamine mixed salts of strengths 5mg,
7.5mg, 10mg, 12.5mg, 15mg, 20mg and 30mg immediate release tablets, the company said in a statement.
COMPANY’S POSITIONING
Positioning is a marketing concept that outlines what a business should do to market its product or service to
its customers. In positioning, the marketing department creates an image for the product based on its
intended audience. This is created through the use of promotion, price, place and product.
Their drive to be the best is unparalleled. Their goal will to match drive by partnering with global leaders in markets,
building lasting relationships, and foundation for mutual growth and success.
SWOT ANALYSIS
• Strong Annual EPS Growth • Declining profits every quarter for the past 4
• Effectively using its capital to generate profit - RoCE improving in last quarters
2 years • Promoter decreasing their shareholding
• Effectively using Shareholders fund - Return on equity (ROE) • Declining Net Cash Flow : Companies not
improving since last 2 year able to generate net cash
• Efficient in managing Assets to generate Profits - ROA improving since • Weak Momentum: Price below Short,
last 2 year Medium and Long Term Averages
• Consistent Highest Return Stocks over Five Years
S W
10 Year PE
• Rising Delivery Percentage
O
• Companies with current TTM PE Ratio less than 3 Year, 5 Year and
T •
•
•
Stocks with Expensive Valuations
according to the Trendlyne Valuation
Score
• Stocks which have buy ratings from at least 4 analysts and have an
upside of at least 20% from their current price.
COMPARE THE SWOT OF YOUR CHOSEN COMPANY WITH
ONE/TWO COMPETITOR/S.
IDENTIFY THE BEST PRACTICES OF THE FIRM
• High volume integrated products where scale and continuous manufacturing is key.
• Medium to high volume complex products: Extended Release, Delayed Release, Multi particulate Pellet system based
products.
• Select first to file and Opportunity products.
• Products that include controlled substances with a focus on Extended & Delayed Release pellet products.
THANK YOU